Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

deCYPher Decipher cytochrome P450 enzymes (CYPs) by digital tools to produce flavonoids and terpenoids

Coordinator
Universiteit Gent, Belgium
Runs
1 September 2023 to 31 August 2027
Status
Running
EU funding
€6.3m
Total cost
€6.3m
Partners
11 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101081782

What the project is doing

In the project's own words, from its summary on CORDIS.

Microbial production of plant metabolites has economic & environmental benefits over traditional extraction and chemical methods. Despite initial progress & the successful market introduction of some molecules, the microbial production of oxygenated plant metabolites (OPMs) mediated by cytochrome P450 enzymes (CYPs) is still lagging, making them almost inaccessible to society. In contrast, artificial intelligence (AI) & machine learning (ML) tools are evolving rapidly, but their use for engineering biology is still underexplored. deCYPher applies these groundbreaking AI/ML techniques to unlock the OPM molecules to society.deCYPher develops a standardised AI/ML pipeline to implement AI/ML in each step of the Design-Build-Test-Learn cycle, and across all steps in the biotech value chain.

Combined with smart databases & synthetic biology (SynBio) tools, this AI/ML pipeline will generate opportunities for the whole biotech sector. Specifically, applied to OPMs, we (1) bioprospect & select specific CYPs, (2) correctly localise & express CYPs and (3) optimise the microbial cells & bioprocess. deCYPher involves stakeholders (industry, regulators, NGOs) and engages European citizens across several countries.

This allows to reflect on the societal ramifications of the convergence of AI & SynBio. The consortium brings together complementary expertise from 5 top RTOs, 3 SMEs, 1 LE & 1 bio-art association from 6 EU countries to unlock the full potential of OPMs. In parallel, deCYPher will enable the AI/ML sector to apply their tools in the biotech sector, by creating new production tools for industrial biotech and specifically impact industry (flavours & fragrances, phytonutrient) and society with novel products. deCYPher contributes to the EU green deal, supports the transition to a circular bioeconomy, increases resource efficiency, strengthens European competitiveness, innovates in a responsible and reflective manner & boosts sustainability of biobased value chains.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit GentGentBelgiumCoordinator
Biofaction KgWienAustriaParticipant
SkyhausGentBelgiumParticipant
Vib VzwZwijnaarde - GentBelgiumParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Barcelona Supercomputing Center Centro Nacional De SupercomputacionBarcelonaSpainParticipant
Suomen Biotaiteen Seura RyHelsinkiFinlandParticipant
Lantana BioToulouseFranceParticipant
Isobionics B.v.GeleenNetherlandsParticipant
Stichting Wageningen ResearchWageningenNetherlandsParticipant
Universidade Nova De LisboaLisboaPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI